Screening protocol to determine high risk cytogenetic features in previously treated CLL

Clinical Trial Grant

Duke Scholars

Principal Investigator Danielle Marie Brander Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

TG Therapeutics, Inc

Start Date

July 1, 2016

End Date

October 19, 2017

Awarded By

TG Therapeutics, Inc

Start Date

July 1, 2016

End Date

October 19, 2017